This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Clinical Services

Aseptic Fill Finish Processing

PCI Clinical Services can offer customised manufacturing of aseptic fill finish treatments for conducting all of your Phase I clinical trials in Australia.

From our dedicated and fully audited facilities in Melbourne, Australia we provide specialized sterile technologies that ensure flexibility, accuracy and speed to market.

  • Aseptic/Sterile Fill for phase 1 Clinical Trials
  • Full randomisation/blinding and delivery to Phase I site “ready to use”
  • Prefilled syringes & Vials (2ml, 5mL, 10mL, 20mL)
  • Infusion bags and syringe pumps
  • Manufactured in excess of 200 batches
  • Peptides, NCEs, biologicals
  • Complex peptide formulations
  • Single use Millipore systems
  • USP Sterility and Endotoxin Testing
  • Filter integrity testing (bubble point)
  • Continuous particulate testing
  • In process assay, pH, appearance
  • Grade C formulation suite
  • HEPA filtered pass throughs
  • Grade B filling suite with Grade A laminar flow
  • Full time microbiologist
  • Trained staff in aseptic processing
  • Full time environmental monitoring staff

Our dedicated team of specialists will be happy to discuss any of our Aseptic Fill and Finish processes with you. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email

Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity... View Article

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued... View Article